References
- Ferrari D, Clementi N, Criscuolo E, et al. Antibody titer kinetics and SARS-CoV-2 infections six months after administration with the BNT162b2 vaccine. Vaccines. 2021;9(11):1357.
- Melgoza-González EA, Hinojosa-Trujillo D, Reséndiz-Sandoval M, et al. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines. Transbound Emerg Dis. 2022;69:e734–e745.
- Naaber P, Tserel L, Kangro K, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur. 2021;10:100208.
- Bayart JL, Douxfils J, Gillot C, et al. Waning of IgG, total and neutralizing antibodies 6 months Post-Vaccination with BNT162b2 in healthcare workers. Vaccines (Basel). 2021;9(10):1092.
- Chan RWY, Liu S, Cheung JY, et al. The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines. Front Immunol. 2021;12(744887).
- Lippi G, Henry BM, Plebani M. Anti-SARS-CoV-2 antibodies testing in recipients of COVID-19 vaccination: Why, when, and how? Diagnostics (Basel). 2021;11(6):941.
- Salvagno GL, Henry BM, Pighi L, et al. The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters. Clin Chem Lab Med. 2022;60(2):e29–e31.
- Lippi G, Salvagno GL, Henry BM, et al. Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination. Adv Lab Med. 2022;3:38–42.
- Heterophilic Blocking Tube, 3IX762.HBT, vs 7. Scantibodies laboratory., Santee, USA.
- Yang J, Ko JH, Baek JY, et al. Effects of Short-Term corticosteroid use on reactogenicity and immunogenicity of the first dose of ChAdOx1 nCoV-19 vaccine. Front Immunol. 2021;12(744206):744206.
- Wisnewski AV, Campillo Luna J, Redlich CA. Human IgG and IgA responses to COVID-19 mRNA vaccines. PLoS ONE. 2021;16(6):e0249499.
- Chan RWY, Liu S, Cheung JY, et al. The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines. Front Immunol. 2021;12:744887.
- Danese E, Montagnana M, Salvagno GL, et al. Comprehensive assessment of humoral response after pfizer BNT162b2 mRNA covid-19 vaccination: a three-case series. Clin Chem Lab Med. 2021;59(9):1585–1591.
- Padoan A, Sciacovelli L, Basso D, et al. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study. Clin Chim Acta. 2020;507:164–166.
- Quinti I, Mortari EP, Fernandez Salinas A, et al. IgA antibodies and IgA deficiency in SARS-CoV-2 infection. Front Cell Infect Microbiol. 2021;11(655896):655896.